Reactivation of Tuberculosis and COVID-19 in Pediatric Patients

Abstract

Objective Mycobacterium tuberculosis is an immobile aerobic bacillus that causes tuberculosis (TB) disease. We aimed to evaluate the association between coronavirus disease 2019 (COVID-19), COVID-19-related drugs, TB reactivation, and TB incidence during the pandemic.

Methods Eight patients who were diagnosed as having TB in Meram Medical Faculty, Necmettin Erbakan University between March 1, 2020, and December 31, 2021, at the beginning of the pandemic, were enrolled in this study. The presence of COVID-19 infection was confirmed using COVID-19 antibody tests and the patients' COVID-19 history. We evaluated the demographic data, laboratory findings, imaging tests, and pathology results of all patients.

Results We checked all our patients with TB using COVID-19 antibodies (immunoglobulin [Ig]G + IgM) or polymerase chain reaction. Seven of the eight patients were female (87.5%). The median age was 16 years. Family screening of all patients was negative, and they had bacillus Calmette–Guérin vaccine scars. Two patients had chronic diseases. One was diagnosed as having primary ciliary dyskinesia in our department (patient no. 8) and the second was under follow-up by the rheumatology department with a diagnosis of juvenile idiopathic rheumatoid arthritis.

Conclusion There has been an increase in the incidence of TB in children, especially in adolescents, during the pandemic period. This may be due to the pathogenic structure of the COVID-19 virus with an unknown mechanism. In addition, lifestyle changes and changes in health care policies during the pandemic may have caused this. Further research should be performed on this topic.

Keywords

COVID-19 - tuberculosis - reactivation

• References

• 1 Suárez I, Fünger SM, Kröger S, Rademacher J, Fätkenheuer G, Rybniker J. The diagnosis and treatment of tuberculosis. Dtsch Arztebl Int 2019; 116 (43) 729-735
• 2 Metry AM, Al Salmi I, Al-Abri S. et al. Epidemiology and outcome of tuberculosis in immunocompromised patients. Saudi J Kidney Dis Transpl 2017; 28 (04) 806-817
• 3 Pekcan S, Tana Aslan A, Kiper N. et al. Multicentric analysis of childhood tuberculosis in Türkiye. Turk J Pediatr 2013; 55 (02) 121-129
• 4 Türkiye tuberculosis guide, 2018, 2019, 2020, 2021 Republic of Türkiye Ministry of Health. Available at: https://hsgm.saglik.gov.tr/depo/birimler/tuberkuloz_db/haberler/Tuberkuloz_Tani_Ve_Tedavi_Rehberi_/Tuberkuloz_Tani_ve_Tedavi_Rehberi.pdf
• 5 World Health Organization (WHO). WHO announces COVID-19 outbreak a pandemic. Accessed September 17, 2022, at: https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/news/news/2020/3/who-announces-covid-19-outbreak-a-pandemic
• 6 Zhang Q, Bastard P, Liu Z. et al; COVID-STORM Clinicians, COVID Clinicians, Imagine COVID Group, French COVID Cohort Study Group, CoV-Contact Cohort, Amsterdam UMC Covid-19 Biobank, COVID Human Genetic Effort, NIAID-USUHS/TAGC COVID Immunity Group. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 2020; 370 (6515): eabd4570
• 7 Béziat V, Tavernier SJ, Chen YH. et al; Undiagnosed Diseases Network. Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome. J Exp Med 2020; 217 (06) e20191804
• 8 Yang H, Lu S. COVID-19 and tuberculosis. J Transl Int Med 2020; 8 (02) 59-65
• 9 Liu W, Fontanet A, Zhang PH. et al. Pulmonary tuberculosis and SARS, China. Emerg Infect Dis 2006; 12 (04) 707-709
• 10 Low JG, Lee CC, Leo YS, Low JG, Lee CC, Leo YS. Severe acute respiratory syndrome and pulmonary tuberculosis. Clin Infect Dis 2004; 38 (12) e123-e125
• 11 Walaza S, Tempia S, Dawood H. et al. Influenza virus infection is associated with increased risk of death amongst patients hospitalized with confirmed pulmonary tuberculosis in South Africa, 2010-2011. BMC Infect Dis 2015; 15: 26
• 12 Mendy J, Jarju S, Heslop R, Bojang AL, Kampmann B, Sutherland JS. Changes in Mycobacterium tuberculosis-specific immunity with influenza co-infection at time of TB diagnosis. Front Immunol 2019; 9: 3093
• 13 Noh JY, Lee J, Choi WS. et al. Concurrent tuberculosis and influenza, South Korea. Emerg Infect Dis 2013; 19 (01) 165-167
• 14 Türkiye statistical institute. Accessed December 2021, at: https://data.tuik.gov.tr/Kategori/GetKategori?p=nufus-ve-demografi-109&dil=1
• 15 Aksu G, Genel F, Koturoğlu G, Kurugöl Z, Kütükçüler N. Serum immunoglobulin (IgG, IgM, IgA) and IgG subclass concentrations in healthy children: a study using nephelometric technique. Turk J Pediatr 2006; Jan-Mar; 48 (01) 19-24
• 16 Ameratunga R, Woon ST, Gillis D, Koopmans W, Steele R. New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin. Clin Exp Immunol 2013; 174 (02) 203-211
• 17 World Health Organization (WHO). Global tuberculosis report. https://www.who.int/teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022
• 18 Starke JR. Tuberculosis in children. Semin Respir Crit Care Med 2004; 25 (03) 353-364
• 19 Scriba TJ, Coussens AK, Fletcher HA. Human immunology of tuberculosis. Microbiol Spectr 2016;4(05)
• 20 Bustamante J. Mendelian susceptibility to mycobacterial disease: recent discoveries. Hum Genet 2020; 139 (6-7): 993-1000
• 21 Conti F, Lugo-Reyes SO, Blancas Galicia L. et al. Mycobacterial disease in patients with chronic granulomatous disease: a retrospective analysis of 71 cases. J Allergy Clin Immunol 2016; 138 (01) 241-248.e3
• 22 Zahid A, Iqbal N, Moeen S, Irfan M. Post COVID-19 tuberculosis: an emerging threat of pandemic. Monaldi Arch Chest Dis 2021;91(03)
• 23 Motta I, Centis R, D'Ambrosio L. et al. Tuberculosis, COVID-19 and migrants: preliminary analysis of deaths occurring in 69 patients from two cohorts. Pulmonology 2020; 26 (04) 233-240
• 24 Gupta N, Ish P, Gupta A. et al. A profile of a retrospective cohort of 22 patients with COVID-19 and active/treated tuberculosis. Eur Respir J 2020; 56 (05) 2003408
• 25 Stochino C, Villa S, Zucchi P, Parravicini P, Gori A, Raviglione MC. Clinical characteristics of COVID-19 and active tuberculosis co-infection in an Italian reference hospital. Eur Respir J 2020; 56 (01) 2001708
• 26 Tadolini M, Codecasa LR, García-García JM. et al. Active tuberculosis, sequelae and COVID-19 co-infection: first cohort of 49 cases. Eur Respir J 2020; 56 (01) 2001398
• 27 Diao B, Wang C, Tan Y. et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol 2020; 11: 827
• 28 Metin Akcan O, Kaman A. Childhood tuberculosis in a reference children's hospital after admission of refugees. J Contemp Med 2021; 11 (02) 160-165